Bain Capital Life Sciences Investors’s Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third PANA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-500,000
Closed -$5M 29
2020
Q3
$5M Buy
+500,000
New +$5M 0.47% 22